Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial.

ABSTRACT:

Background

There is a dearth of research on the cost-effectiveness of intensive home treatment (IHT), an alternative to psychiatric hospitalisation for patients experiencing psychiatric crises. We therefore present a health economic evaluation alongside a pre-randomised controlled trial of IHT compared to care as usual (CAU).

Method

Patients were pre-randomised to IHT or CAU using a double-consent open-label Zelen design. For the cost-utility analysis, the EuroQol 5-dimensional instrument was used. The cost-effectiveness was assessed using the Brief Psychiatric Rating Scale (BPRS).

Results

Data of 198 patients showed that each additional QALY gained from offering IHT instead of CAU was on average associated with an extra cost of €48,003. There is a 38% likelihood that

SUBMITTER: Barakat A 

PROVIDER: S-EPMC11743399 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature